Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression

Abstract We examined the autocrine/paracrine role of interleukin-8 (CXCL8) and the functional significance of CXCL8 receptors, CXCR1 and CXCR2, in human malignant melanoma proliferation, migration, invasion and angiogenesis. We found that a panel of seven cell lines, even though at different extent,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cancer (1990) 2009-09, Vol.45 (14), p.2618-2627
Hauptverfasser: Gabellini, Chiara, Trisciuoglio, Daniela, Desideri, Marianna, Candiloro, Antonio, Ragazzoni, Ylenia, Orlandi, Augusto, Zupi, Gabriella, Del Bufalo, Donatella
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2627
container_issue 14
container_start_page 2618
container_title European journal of cancer (1990)
container_volume 45
creator Gabellini, Chiara
Trisciuoglio, Daniela
Desideri, Marianna
Candiloro, Antonio
Ragazzoni, Ylenia
Orlandi, Augusto
Zupi, Gabriella
Del Bufalo, Donatella
description Abstract We examined the autocrine/paracrine role of interleukin-8 (CXCL8) and the functional significance of CXCL8 receptors, CXCR1 and CXCR2, in human malignant melanoma proliferation, migration, invasion and angiogenesis. We found that a panel of seven cell lines, even though at different extent, secreted CXCL8 protein, and expressed CXCR1 and CXCR2 independently from the CXCL8 expression, but depending on the oxygen level. In fact, hypoxic exposure increases the expression of CXCR1 and CXCR2. The cell proliferation of both M20 and A375SM lines, expressing similar levels of both CXCR1 and CXCR2 but secreting low and high amounts of CXCL8, respectively, was significantly enhanced by CXCL8 exposure and reduced by CXCL8, CXCR1 and CXCR2 neutralising antibodies, indicating the autocrine/paracrine role of CXCL8 in melanoma cell proliferation. Moreover, an increased invasion and migration in response to CXCL8 was observed in several cell lines, and a further enhancement evidenced under hypoxic conditions. A CXCL8-dependent in vivo vessel formation, evaluated through a matrigel assay, was also demonstrated. Furthermore, when neutralising antibodies against CXCR1 or CXCR2 were used, only the involvement of CXCR2, but not CXCR1 was observed on cell migration and invasion, while both receptors played a role in angiogenesis. In summary, our data demonstrate that CXCL8 induces cell proliferation and angiogenesis through both receptors and that CXCR2 plays an important role in regulating the CXCL8-mediated invasive and migratory behaviour of human melanoma cells. Thus, blocking the CXCL8 signalling axis promises an improvement for the therapy of cancer and, in particular, of metastatic melanoma.
doi_str_mv 10.1016/j.ejca.2009.07.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67621711</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0959804909005449</els_id><sourcerecordid>21086665</sourcerecordid><originalsourceid>FETCH-LOGICAL-c536t-ff7366a6600d0460acb9efe35f9f175284740518d596846e9e1bd460e7bc0ea23</originalsourceid><addsrcrecordid>eNqFkl2r1DAQhosonvXoH_BCcqNXp3WStvkAEWTxqLAg-AHexWw6Paa2yZq0B_bfm7qLghd6lSE87zvDvFMUjylUFCh_PlQ4WFMxAFWBqADEnWJDpVAlyJbdLTagWlVKaNRF8SClATIhG7hfXFDFZd3UsCm-Xi_ezi54MxKTi1s3H0noyfbLdidJRIuHOcR0tX58oMT47lfFrkjw5NsyGU8mM7obb_xMJhyND5MhhxhuIqaUfR8W93ozJnx0fi-Lz9evP23flrv3b95tX-1K29Z8Lvte1JwbzgE6aDgYu1fYY932qqeiZbIRDbRUdm0eveGokO67zKHYW0DD6svi2ck39_6xYJr15JLFMU-EYUmaC86ooPS_IKMgOedtBtkJtDGkFLHXh-gmE4-agl4D0INeA9BrABqEzuvNoidn92U_YfdHct54Bp6eAZOsGftovHXpN8eoqhXUMnMvThzmpd06jDpZh95i53Iqs-6C-_ccL_-S29F5lzt-xyOmISwxR5401Ylp0B_XU1kvBRRA2zSq_gkY9rbE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21086665</pqid></control><display><type>article</type><title>Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Gabellini, Chiara ; Trisciuoglio, Daniela ; Desideri, Marianna ; Candiloro, Antonio ; Ragazzoni, Ylenia ; Orlandi, Augusto ; Zupi, Gabriella ; Del Bufalo, Donatella</creator><creatorcontrib>Gabellini, Chiara ; Trisciuoglio, Daniela ; Desideri, Marianna ; Candiloro, Antonio ; Ragazzoni, Ylenia ; Orlandi, Augusto ; Zupi, Gabriella ; Del Bufalo, Donatella</creatorcontrib><description>Abstract We examined the autocrine/paracrine role of interleukin-8 (CXCL8) and the functional significance of CXCL8 receptors, CXCR1 and CXCR2, in human malignant melanoma proliferation, migration, invasion and angiogenesis. We found that a panel of seven cell lines, even though at different extent, secreted CXCL8 protein, and expressed CXCR1 and CXCR2 independently from the CXCL8 expression, but depending on the oxygen level. In fact, hypoxic exposure increases the expression of CXCR1 and CXCR2. The cell proliferation of both M20 and A375SM lines, expressing similar levels of both CXCR1 and CXCR2 but secreting low and high amounts of CXCL8, respectively, was significantly enhanced by CXCL8 exposure and reduced by CXCL8, CXCR1 and CXCR2 neutralising antibodies, indicating the autocrine/paracrine role of CXCL8 in melanoma cell proliferation. Moreover, an increased invasion and migration in response to CXCL8 was observed in several cell lines, and a further enhancement evidenced under hypoxic conditions. A CXCL8-dependent in vivo vessel formation, evaluated through a matrigel assay, was also demonstrated. Furthermore, when neutralising antibodies against CXCR1 or CXCR2 were used, only the involvement of CXCR2, but not CXCR1 was observed on cell migration and invasion, while both receptors played a role in angiogenesis. In summary, our data demonstrate that CXCL8 induces cell proliferation and angiogenesis through both receptors and that CXCR2 plays an important role in regulating the CXCL8-mediated invasive and migratory behaviour of human melanoma cells. Thus, blocking the CXCL8 signalling axis promises an improvement for the therapy of cancer and, in particular, of metastatic melanoma.</description><identifier>ISSN: 0959-8049</identifier><identifier>EISSN: 1879-0852</identifier><identifier>DOI: 10.1016/j.ejca.2009.07.007</identifier><identifier>PMID: 19683430</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Animals ; Biological and medical sciences ; Cell hypoxia ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Chemotaxis ; CXCR1 ; CXCR2 ; Hematology, Oncology and Palliative Medicine ; Humans ; Interleukin-8 ; Interleukin-8 - metabolism ; Medical sciences ; Melanoma ; Melanoma - blood supply ; Melanoma - metabolism ; Mice ; Mice, Nude ; Neoplasm Invasiveness ; Neoplasm Proteins - metabolism ; Neovascularization, Pathologic - etiology ; Pathologic neovascularisation ; Pharmacology. Drug treatments ; Receptors, Interleukin-8A - metabolism ; Receptors, Interleukin-8B - metabolism ; Tumors</subject><ispartof>European journal of cancer (1990), 2009-09, Vol.45 (14), p.2618-2627</ispartof><rights>Elsevier Ltd</rights><rights>2009 Elsevier Ltd</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c536t-ff7366a6600d0460acb9efe35f9f175284740518d596846e9e1bd460e7bc0ea23</citedby><cites>FETCH-LOGICAL-c536t-ff7366a6600d0460acb9efe35f9f175284740518d596846e9e1bd460e7bc0ea23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejca.2009.07.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21939038$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19683430$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gabellini, Chiara</creatorcontrib><creatorcontrib>Trisciuoglio, Daniela</creatorcontrib><creatorcontrib>Desideri, Marianna</creatorcontrib><creatorcontrib>Candiloro, Antonio</creatorcontrib><creatorcontrib>Ragazzoni, Ylenia</creatorcontrib><creatorcontrib>Orlandi, Augusto</creatorcontrib><creatorcontrib>Zupi, Gabriella</creatorcontrib><creatorcontrib>Del Bufalo, Donatella</creatorcontrib><title>Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression</title><title>European journal of cancer (1990)</title><addtitle>Eur J Cancer</addtitle><description>Abstract We examined the autocrine/paracrine role of interleukin-8 (CXCL8) and the functional significance of CXCL8 receptors, CXCR1 and CXCR2, in human malignant melanoma proliferation, migration, invasion and angiogenesis. We found that a panel of seven cell lines, even though at different extent, secreted CXCL8 protein, and expressed CXCR1 and CXCR2 independently from the CXCL8 expression, but depending on the oxygen level. In fact, hypoxic exposure increases the expression of CXCR1 and CXCR2. The cell proliferation of both M20 and A375SM lines, expressing similar levels of both CXCR1 and CXCR2 but secreting low and high amounts of CXCL8, respectively, was significantly enhanced by CXCL8 exposure and reduced by CXCL8, CXCR1 and CXCR2 neutralising antibodies, indicating the autocrine/paracrine role of CXCL8 in melanoma cell proliferation. Moreover, an increased invasion and migration in response to CXCL8 was observed in several cell lines, and a further enhancement evidenced under hypoxic conditions. A CXCL8-dependent in vivo vessel formation, evaluated through a matrigel assay, was also demonstrated. Furthermore, when neutralising antibodies against CXCR1 or CXCR2 were used, only the involvement of CXCR2, but not CXCR1 was observed on cell migration and invasion, while both receptors played a role in angiogenesis. In summary, our data demonstrate that CXCL8 induces cell proliferation and angiogenesis through both receptors and that CXCR2 plays an important role in regulating the CXCL8-mediated invasive and migratory behaviour of human melanoma cells. Thus, blocking the CXCL8 signalling axis promises an improvement for the therapy of cancer and, in particular, of metastatic melanoma.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cell hypoxia</subject><subject>Cell Line, Tumor</subject><subject>Cell Movement</subject><subject>Cell Proliferation</subject><subject>Chemotaxis</subject><subject>CXCR1</subject><subject>CXCR2</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Interleukin-8</subject><subject>Interleukin-8 - metabolism</subject><subject>Medical sciences</subject><subject>Melanoma</subject><subject>Melanoma - blood supply</subject><subject>Melanoma - metabolism</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Proteins - metabolism</subject><subject>Neovascularization, Pathologic - etiology</subject><subject>Pathologic neovascularisation</subject><subject>Pharmacology. Drug treatments</subject><subject>Receptors, Interleukin-8A - metabolism</subject><subject>Receptors, Interleukin-8B - metabolism</subject><subject>Tumors</subject><issn>0959-8049</issn><issn>1879-0852</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkl2r1DAQhosonvXoH_BCcqNXp3WStvkAEWTxqLAg-AHexWw6Paa2yZq0B_bfm7qLghd6lSE87zvDvFMUjylUFCh_PlQ4WFMxAFWBqADEnWJDpVAlyJbdLTagWlVKaNRF8SClATIhG7hfXFDFZd3UsCm-Xi_ezi54MxKTi1s3H0noyfbLdidJRIuHOcR0tX58oMT47lfFrkjw5NsyGU8mM7obb_xMJhyND5MhhxhuIqaUfR8W93ozJnx0fi-Lz9evP23flrv3b95tX-1K29Z8Lvte1JwbzgE6aDgYu1fYY932qqeiZbIRDbRUdm0eveGokO67zKHYW0DD6svi2ck39_6xYJr15JLFMU-EYUmaC86ooPS_IKMgOedtBtkJtDGkFLHXh-gmE4-agl4D0INeA9BrABqEzuvNoidn92U_YfdHct54Bp6eAZOsGftovHXpN8eoqhXUMnMvThzmpd06jDpZh95i53Iqs-6C-_ccL_-S29F5lzt-xyOmISwxR5401Ylp0B_XU1kvBRRA2zSq_gkY9rbE</recordid><startdate>20090901</startdate><enddate>20090901</enddate><creator>Gabellini, Chiara</creator><creator>Trisciuoglio, Daniela</creator><creator>Desideri, Marianna</creator><creator>Candiloro, Antonio</creator><creator>Ragazzoni, Ylenia</creator><creator>Orlandi, Augusto</creator><creator>Zupi, Gabriella</creator><creator>Del Bufalo, Donatella</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20090901</creationdate><title>Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression</title><author>Gabellini, Chiara ; Trisciuoglio, Daniela ; Desideri, Marianna ; Candiloro, Antonio ; Ragazzoni, Ylenia ; Orlandi, Augusto ; Zupi, Gabriella ; Del Bufalo, Donatella</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c536t-ff7366a6600d0460acb9efe35f9f175284740518d596846e9e1bd460e7bc0ea23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cell hypoxia</topic><topic>Cell Line, Tumor</topic><topic>Cell Movement</topic><topic>Cell Proliferation</topic><topic>Chemotaxis</topic><topic>CXCR1</topic><topic>CXCR2</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Interleukin-8</topic><topic>Interleukin-8 - metabolism</topic><topic>Medical sciences</topic><topic>Melanoma</topic><topic>Melanoma - blood supply</topic><topic>Melanoma - metabolism</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Proteins - metabolism</topic><topic>Neovascularization, Pathologic - etiology</topic><topic>Pathologic neovascularisation</topic><topic>Pharmacology. Drug treatments</topic><topic>Receptors, Interleukin-8A - metabolism</topic><topic>Receptors, Interleukin-8B - metabolism</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gabellini, Chiara</creatorcontrib><creatorcontrib>Trisciuoglio, Daniela</creatorcontrib><creatorcontrib>Desideri, Marianna</creatorcontrib><creatorcontrib>Candiloro, Antonio</creatorcontrib><creatorcontrib>Ragazzoni, Ylenia</creatorcontrib><creatorcontrib>Orlandi, Augusto</creatorcontrib><creatorcontrib>Zupi, Gabriella</creatorcontrib><creatorcontrib>Del Bufalo, Donatella</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cancer (1990)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gabellini, Chiara</au><au>Trisciuoglio, Daniela</au><au>Desideri, Marianna</au><au>Candiloro, Antonio</au><au>Ragazzoni, Ylenia</au><au>Orlandi, Augusto</au><au>Zupi, Gabriella</au><au>Del Bufalo, Donatella</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression</atitle><jtitle>European journal of cancer (1990)</jtitle><addtitle>Eur J Cancer</addtitle><date>2009-09-01</date><risdate>2009</risdate><volume>45</volume><issue>14</issue><spage>2618</spage><epage>2627</epage><pages>2618-2627</pages><issn>0959-8049</issn><eissn>1879-0852</eissn><abstract>Abstract We examined the autocrine/paracrine role of interleukin-8 (CXCL8) and the functional significance of CXCL8 receptors, CXCR1 and CXCR2, in human malignant melanoma proliferation, migration, invasion and angiogenesis. We found that a panel of seven cell lines, even though at different extent, secreted CXCL8 protein, and expressed CXCR1 and CXCR2 independently from the CXCL8 expression, but depending on the oxygen level. In fact, hypoxic exposure increases the expression of CXCR1 and CXCR2. The cell proliferation of both M20 and A375SM lines, expressing similar levels of both CXCR1 and CXCR2 but secreting low and high amounts of CXCL8, respectively, was significantly enhanced by CXCL8 exposure and reduced by CXCL8, CXCR1 and CXCR2 neutralising antibodies, indicating the autocrine/paracrine role of CXCL8 in melanoma cell proliferation. Moreover, an increased invasion and migration in response to CXCL8 was observed in several cell lines, and a further enhancement evidenced under hypoxic conditions. A CXCL8-dependent in vivo vessel formation, evaluated through a matrigel assay, was also demonstrated. Furthermore, when neutralising antibodies against CXCR1 or CXCR2 were used, only the involvement of CXCR2, but not CXCR1 was observed on cell migration and invasion, while both receptors played a role in angiogenesis. In summary, our data demonstrate that CXCL8 induces cell proliferation and angiogenesis through both receptors and that CXCR2 plays an important role in regulating the CXCL8-mediated invasive and migratory behaviour of human melanoma cells. Thus, blocking the CXCL8 signalling axis promises an improvement for the therapy of cancer and, in particular, of metastatic melanoma.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>19683430</pmid><doi>10.1016/j.ejca.2009.07.007</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0959-8049
ispartof European journal of cancer (1990), 2009-09, Vol.45 (14), p.2618-2627
issn 0959-8049
1879-0852
language eng
recordid cdi_proquest_miscellaneous_67621711
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Animals
Biological and medical sciences
Cell hypoxia
Cell Line, Tumor
Cell Movement
Cell Proliferation
Chemotaxis
CXCR1
CXCR2
Hematology, Oncology and Palliative Medicine
Humans
Interleukin-8
Interleukin-8 - metabolism
Medical sciences
Melanoma
Melanoma - blood supply
Melanoma - metabolism
Mice
Mice, Nude
Neoplasm Invasiveness
Neoplasm Proteins - metabolism
Neovascularization, Pathologic - etiology
Pathologic neovascularisation
Pharmacology. Drug treatments
Receptors, Interleukin-8A - metabolism
Receptors, Interleukin-8B - metabolism
Tumors
title Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T11%3A11%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functional%20activity%20of%20CXCL8%20receptors,%20CXCR1%20and%20CXCR2,%20on%20human%20malignant%20melanoma%20progression&rft.jtitle=European%20journal%20of%20cancer%20(1990)&rft.au=Gabellini,%20Chiara&rft.date=2009-09-01&rft.volume=45&rft.issue=14&rft.spage=2618&rft.epage=2627&rft.pages=2618-2627&rft.issn=0959-8049&rft.eissn=1879-0852&rft_id=info:doi/10.1016/j.ejca.2009.07.007&rft_dat=%3Cproquest_cross%3E21086665%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21086665&rft_id=info:pmid/19683430&rft_els_id=1_s2_0_S0959804909005449&rfr_iscdi=true